SCHEMBL13864993

SCHEMBL13864993

CC(=O)Oc1cc(Br)c(OC(C)=O)c(Br)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.50
ALOX5 P09917 2/20 0.45
LMNA P02545 3/20 0.43
CYP3A4 P08684 2/20 0.43
MAPT P10636 2/20 0.43
KDM4E B2RXH2 2/20 0.43
MEN1 O00255 1/20 0.43
TTR P02766 1/20 0.43
TP53 P04637 1/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CYP4F2 P78329 1/20 0.42
CYP4A11 Q02928 1/20 0.42
TUBB4A P04350 2/20 0.40
TUBB P07437 2/20 0.40
TUBA3C P0DPH7 2/20 0.40
TUBA1B P68363 2/20 0.40
TUBA4A P68366 2/20 0.40
TUBB4B P68371 2/20 0.40
TUBB3 Q13509 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7225909 0.89 MAPT (0.47) BACE1ALOX5LMNACYP3A4MAPT
SCHEMBL6936490 0.84 PREP (0.46) BACE1MAPTKDM4EMEN1TP53
SCHEMBL4647729 0.84 HSD17B10 (0.50) BACE1CYP3A4MAPTKDM4EMEN1
SCHEMBL7827341 0.83 PREP (0.48) BACE1ALOX5CYP3A4MAPTKDM4E
SCHEMBL14430071 0.83 KDM4E (0.44) BACE1LMNAMAPTKDM4EMEN1
SCHEMBL7114628 0.83 CYP3A4 (0.47) BACE1ALOX5LMNACYP3A4MAPT
SCHEMBL9863397 0.81 TPMT (0.42) BACE1LMNAMAPTKDM4EMEN1
SCHEMBL7112160 0.80 BACE1 (0.52) BACE1LMNACYP3A4MAPTKDM4E
SCHEMBL18281058 0.79 TPMT (0.58) BACE1LMNAKDM4EMEN1TTR
SCHEMBL2010436 0.78 LMNA (0.59) BACE1LMNACYP3A4MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7534371-B2 Liquid crystalline compound, liquid crystalline composition and retardation film FUJIFILM CORPORATION (JP) 2009-05-19 US disclosed
US-7534371-B2 Liquid crystalline compound, liquid crystalline composition and retardation film FUJIFILM CORPORATION (JP) 2009-05-19 US disclosed
US-20080169448-A1 Liquid crystalline compound, liquid crystalline composition and retardation film FUJIFILM CORPORATION (JP) 2008-07-17 US disclosed
US-20080169448-A1 Liquid crystalline compound, liquid crystalline composition and retardation film FUJIFILM CORPORATION (JP) 2008-07-17 US disclosed
US-7364670-B2 Liquid crystalline compound, liquid crystalline composition and retardation film FUJIFILM CORPORATION (JP) 2008-04-29 US disclosed
US-7169325-B2 Liquid crystalline compound, liquid crystalline composition and retardation film FUJI PHOTO FILM CO., LTD. (JP) 2007-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080169448-A1 Liquid crystalline compound, liquid crystalline composition and retardation film NCAPD2, RCC1, CCND2 BACE1 1290/4885ALOX5 3353/4885LMNA 496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.